CASI PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Net
CASI PHARMACEUTICALS, INC. had Finite-Lived Intangible Assets, Net of $1.06 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2023-04-26
- 2022-12-31: Finite-Lived Intangible Assets, Net $1.06M.
- 2021-12-31: Finite-Lived Intangible Assets, Net $12.20M.
- 2021-09-30: Finite-Lived Intangible Assets, Net $12.36M.
- 2021-06-30: Finite-Lived Intangible Assets, Net $12.69M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2022-12-31 | $1.06M 20-F · filed 2023-04-26 | |
| 2021-12-31 | $12.20M 20-F · filed 2023-04-26 | |
| 2021-09-30 | $12.36M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $12.69M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $12.83M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $13.21M 20-F · filed 2023-04-26 | |
| 2020-06-30 | $13.14M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $16.29M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $13.67M 20-F · filed 2023-04-26 | $16.89M 10-K · filed 2020-03-16 |
| 2019-09-30 | $17.27M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $18.79M 10-K · filed 2020-03-16 |